Literature DB >> 15920531

Focus on recombinational DNA repair.

Lorraine S Symington1.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15920531      PMCID： PMC1369096          DOI： 10.1038/sj.embor.7400438

Source DB:  PubMed          Journal:  EMBO Rep        ISSN： 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  29 in total

Review 1.  Initiation of genetic recombination and recombination-dependent replication.

Authors:  S C Kowalczykowski
Journal:  Trends Biochem Sci       Date:  2000-04       Impact factor: 13.807

2.  RecFOR proteins load RecA protein onto gapped DNA to accelerate DNA strand exchange: a universal step of recombinational repair.

Authors:  Katsumi Morimatsu; Stephen C Kowalczykowski
Journal:  Mol Cell       Date:  2003-05       Impact factor: 17.970

Review 3.  Molecular views of recombination proteins and their control.

Authors:  Stephen C West
Journal:  Nat Rev Mol Cell Biol       Date:  2003-06       Impact factor: 94.444

4.  A novel function of Rad54 protein. Stabilization of the Rad51 nucleoprotein filament.

Authors:  Alexander V Mazin; Andrei A Alexeev; Stephen C Kowalczykowski
Journal:  J Biol Chem       Date:  2003-02-03       Impact factor: 5.157

5.  Impairment of replication fork progression mediates RNA polII transcription-associated recombination.

Authors:  Félix Prado; Andrés Aguilera
Journal:  EMBO J       Date:  2005-03-03       Impact factor: 11.598

6.  Human Rad50/Mre11 is a flexible complex that can tether DNA ends.

Authors:  M de Jager; J van Noort; D C van Gent; C Dekker; R Kanaar; C Wyman
Journal:  Mol Cell       Date:  2001-11       Impact factor: 17.970

7.  The Hop2 protein has a direct role in promoting interhomolog interactions during mouse meiosis.

Authors:  Galina V Petukhova; Peter J Romanienko; R Daniel Camerini-Otero
Journal:  Dev Cell       Date:  2003-12       Impact factor: 12.270

8.  Fork reversal and ssDNA accumulation at stalled replication forks owing to checkpoint defects.

Authors:  José M Sogo; Massimo Lopes; Marco Foiani
Journal:  Science       Date:  2002-07-26       Impact factor: 47.728

9.  In vivo roles of Rad52, Rad54, and Rad55 proteins in Rad51-mediated recombination.

Authors:  Neal Sugawara; Xuan Wang; James E Haber
Journal:  Mol Cell       Date:  2003-07       Impact factor: 17.970

10.  Mutations in yeast Rad51 that partially bypass the requirement for Rad55 and Rad57 in DNA repair by increasing the stability of Rad51-DNA complexes.

Authors:  Gary S Fortin; Lorraine S Symington
Journal:  EMBO J       Date:  2002-06-17       Impact factor: 11.598
View more
  6 in total

1.  Role of the short telomeric repeat region in Marek's disease virus replication, genomic integration, and lymphomagenesis.

Authors:  Annachiara Greco; Nadine Fester; Annemarie T Engel; Benedikt B Kaufer
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

Review 2.  Chlamydomonas reinhardtii: a convenient model system for the study of DNA repair in photoautotrophic eukaryotes.

Authors:  Daniel Vlcek; Andrea Sevcovicová; Barbara Sviezená; Eliska Gálová; Eva Miadoková
Journal:  Curr Genet       Date:  2007-11-09       Impact factor: 3.886

3.  Highly conserved regimes of neighbor-base-dependent mutation generated the background primary-structural heterogeneities along vertebrate chromosomes.

Authors:  Marcos A Antezana; I King Jordan
Journal:  PLoS One       Date:  2008-05-14       Impact factor: 3.240

4.  Repair of single-point mutations by polypurine reverse Hoogsteen hairpins.

Authors:  Anna Solé; Xenia Villalobos; Carlos J Ciudad; Véronique Noé
Journal:  Hum Gene Ther Methods       Date:  2014-10-14       Impact factor: 2.396

Review 5.  Synthetic lethal approaches to breast cancer therapy.

Authors:  Farah L Rehman; Christopher J Lord; Alan Ashworth
Journal:  Nat Rev Clin Oncol       Date:  2010-10-19       Impact factor: 66.675

6.  Results of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive immune response in patients with stage II-IV breast cancer.

Authors:  Anastasia S Proskurina; Tatiana S Gvozdeva; Ekaterina A Alyamkina; Evgenia V Dolgova; Konstantin E Orishchenko; Valeriy P Nikolin; Nelly A Popova; Sergey V Sidorov; Elena R Chernykh; Alexandr A Ostanin; Olga Y Leplina; Victoria V Dvornichenko; Dmitriy M Ponomarenko; Galina S Soldatova; Nikolay A Varaksin; Tatiana G Ryabicheva; Peter N Uchakin; Stanislav N Zagrebelniy; Vladimir A Rogachev; Sergey S Bogachev; Mikhail A Shurdov
Journal:  BMC Cancer       Date:  2015-03-13       Impact factor: 4.430
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.